Virtus ETF Advisers LLC G1 Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $61,359 - $129,249	-15,188 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $6,840 - $9,918	-900 Reduced 5.59%	15,188 $115,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $68,529 - $109,066	6,745 Added 72.19%	16,088 $164,000
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $6,435 - $10,987	-489 Reduced 4.97%	9,343 $125,000
Q2 2021 Aug 10, 2021	SELL	$19.57 - $26.32 $107,380 - $144,417	-5,487 Reduced 35.82%	9,832 $216,000
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $4,641 - $8,603	264 Added 1.75%	15,319 $369,000
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $18,221 - $33,823	-1,658 Reduced 9.92%	15,055 $271,000
Q3 2020 Nov 13, 2020	SELL	$11.55 - $23.75 $26,310 - $54,102	-2,278 Reduced 12.0%	16,713 $193,000
Q2 2020 Aug 05, 2020	BUY	$9.57 - $24.37 $42,375 - $107,910	4,428 Added 30.41%	18,991 $461,000
Q1 2020 May 14, 2020	SELL	$9.07 - $26.32 $19,237 - $55,824	-2,121 Reduced 12.71%	14,563 $160,000
Q4 2019 Feb 13, 2020	BUY	$20.54 - $31.0 $63,283 - $95,511	3,081 Added 22.65%	16,684 $441,000
Q3 2019 Nov 12, 2019	SELL	$22.78 - $40.58 $17,244 - $30,719	-757 Reduced 5.27%	13,603 $310,000
Q2 2019 Aug 13, 2019	BUY	$16.03 - $31.1 $91,467 - $177,456	5,706 Added 65.93%	14,360 $440,000
Q1 2019 May 14, 2019	SELL	$14.4 - $21.45 $18,720 - $27,885	-1,300 Reduced 13.06%	8,654 $144,000
Q4 2018 Feb 05, 2019	SELL	$16.51 - $51.33 $10,021 - $31,157	-607 Reduced 5.75%	9,954 $191,000
Q3 2018 Nov 14, 2018	SELL	$43.15 - $67.97 $325,437 - $512,629	-7,542 Reduced 41.66%	10,561 $552,000
Q2 2018 Aug 10, 2018	SELL	$35.06 - $51.17 $701,971 - $1.02 Million	-20,022 Reduced 52.52%	18,103 $787,000
Q1 2018 May 14, 2018	BUY	$19.05 - $41.76 $390,105 - $855,161	20,478 Added 116.04%	38,125 $1.41 Million
Q4 2017 Feb 14, 2018	BUY	$19.01 - $26.2 $335,469 - $462,351	17,647	17,647 $350,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account